Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Whitepaper
Assessing the epigenetics of T cell exhaustion using CRISPR screens
A major challenge in therapeutic immuno-oncology today is the limited persistence of CAR-T cells. Many studies have focused on altering CAR structure and regulating CAR-T cell differentiation to optimize their clinical efficacy. Research is also focused on identifying new molecular targets to reduce T cell exhaustion. In this white paper, we share an interview with Dr. Verena Brucklacher-Waldert of Revvity, who discusses the epigenetics of T cell exhaustion and practical techniques to assess immune cell epigenetic regulators using CRISPS screens. For research use only. Not for use in diagnostic procedures.
A major challenge in therapeutic immuno-oncology today is the limited persistence of CAR-T cells. Many studies have focused on altering CAR structure and regulating CAR-T cell differentiation to optimize their clinical efficacy. Research is also focused on identifying new molecular targets to reduce T cell exhaustion.
In this white paper, we share an interview with Dr. Verena Brucklacher-Waldert of Revvity, who discusses the epigenetics of T cell exhaustion and practical techniques to assess immune cell epigenetic regulators using CRISPS screens.
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Assessing the epigenetics of T cell exhaustion using CRISPR screens